CWA Asset Management Group LLC boosted its holdings in Nutanix, Inc. (NASDAQ:NTNX – Free Report) by 30.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,283 shares of the technology company’s stock after purchasing an additional 5,475 shares during the quarter. CWA Asset Management Group LLC’s holdings in Nutanix were worth $1,424,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. Bain Capital Investors LLC acquired a new stake in shares of Nutanix in the third quarter valued at approximately $998,601,000. Driehaus Capital Management LLC increased its stake in Nutanix by 123.9% during the 2nd quarter. Driehaus Capital Management LLC now owns 1,435,230 shares of the technology company’s stock worth $81,593,000 after acquiring an additional 794,215 shares during the period. Two Sigma Advisers LP raised its holdings in Nutanix by 32.8% in the 3rd quarter. Two Sigma Advisers LP now owns 2,814,002 shares of the technology company’s stock valued at $166,730,000 after acquiring an additional 695,567 shares in the last quarter. Marshall Wace LLP lifted its position in shares of Nutanix by 47.5% during the 2nd quarter. Marshall Wace LLP now owns 1,482,989 shares of the technology company’s stock valued at $84,308,000 after acquiring an additional 477,838 shares during the period. Finally, Jacobs Levy Equity Management Inc. grew its holdings in shares of Nutanix by 15.3% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 2,816,647 shares of the technology company’s stock worth $166,886,000 after purchasing an additional 374,328 shares in the last quarter. Institutional investors own 85.25% of the company’s stock.
Nutanix Trading Up 2.3 %
NASDAQ:NTNX opened at $64.11 on Tuesday. The stock’s 50-day moving average is $66.42 and its 200-day moving average is $59.98. Nutanix, Inc. has a 1-year low of $43.35 and a 1-year high of $75.80. The stock has a market cap of $17.18 billion, a P/E ratio of -183.17, a price-to-earnings-growth ratio of 10.34 and a beta of 1.16.
Insider Buying and Selling
Wall Street Analyst Weigh In
NTNX has been the subject of several recent analyst reports. Piper Sandler upped their price objective on shares of Nutanix from $77.00 to $83.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Barclays increased their price target on shares of Nutanix from $75.00 to $87.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Northland Securities restated a “market perform” rating and set a $77.00 price objective (up from $74.00) on shares of Nutanix in a research report on Wednesday, November 27th. StockNews.com raised Nutanix from a “buy” rating to a “strong-buy” rating in a report on Thursday, November 28th. Finally, Needham & Company LLC boosted their price target on Nutanix from $80.00 to $90.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.47.
Read Our Latest Research Report on NTNX
Nutanix Company Profile
Nutanix, Inc engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure.
Recommended Stories
- Five stocks we like better than Nutanix
- How to Calculate Inflation Rate
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Upcoming IPO Stock Lockup Period, Explained
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- What is the MACD Indicator and How to Use it in Your Trading
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.